Classic Congenital Adrenal Hyperplasia clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
open to eligible people ages 1-17
The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of atumelnant treatment in pediatric participants with classic congenital adrenal hyperplasia (CAH).
at UCSF
Last updated: